Madelyn E. Burkart

Hematology
1 Medical Ctr Blvd
Winston Salem, NC 27103

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Challenges in the treatment of adolescent and young adult acute lymphoblastic leukemia: A comprehensive review.

Challenges in the treatment of adolescent and young adult acute lymphoblastic leukemia: A comprehensive review.

Journal: Blood reviews
Published: February 18, 2026

Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.

Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.

Journal: Haematologica
Published: August 31, 2025

Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials.

Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials.

Journal: Blood
Published: July 18, 2025

Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.

Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.

Journal: Blood cancer journal
Published: June 18, 2025

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.

Journal: Blood advances
Published: December 24, 2024

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms.

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms.

Journal: Blood neoplasia
Published: December 19, 2024

Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.

Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.

Journal: Blood advances
Published: April 05, 2024

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Journal: Blood advances
Published: February 06, 2024

Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.

Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.

Journal: Blood reviews
Published: January 22, 2024

Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases.

Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases.

Journal: Haematologica
Published: January 06, 2024

Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Journal: Leukemia
Published: December 15, 2022

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.

Journal: Blood advances
Published: October 24, 2022
Showing 1-12 of 39

Last Updated: 09/26/2026